The Binding of Triclosan to SmeT, the Repressor of the Multidrug Efflux Pump SmeDEF, Induces Antibiotic Resistance in
The wide utilization of biocides poses a concern on the impact of these compounds on natural bacterial populations. Furthermore, it has been demonstrated that biocides can select, at least in laboratory experiments, antibiotic resistant bacteria. This situation has raised concerns, not just on scientists and clinicians, but also on regulatory agencies, which are demanding studies on the impact that the utilization of biocides may have on the development on resistance and consequently on the treatment of infectious diseases and on human health. In the present article, we explored the possibility that the widely used biocide triclosan might induce antibiotic resistance using as a model the opportunistic pathogen Stenotrophomonas maltophilia. Biochemical, functional and structural studies were performed, focusing on SmeDEF, the most relevant antibiotic- and triclosan-removing multidrug efflux pump of S. maltophilia. Expression of smeDEF is regulated by the repressor SmeT. Triclosan released SmeT from its operator and induces the expression of smeDEF, thus reducing the susceptibility of S. maltophilia to antibiotics in the presence of the biocide. The structure of SmeT bound to triclosan is described. Two molecules of triclosan were found to bind to one subunit of the SmeT homodimer. The binding of the biocide stabilizes the N terminal domain of both subunits in a conformation unable to bind DNA. To our knowledge this is the first crystal structure obtained for a transcriptional regulator bound to triclosan. This work provides the molecular basis for understanding the mechanisms allowing the induction of phenotypic resistance to antibiotics by triclosan.
Vyšlo v časopise:
The Binding of Triclosan to SmeT, the Repressor of the Multidrug Efflux Pump SmeDEF, Induces Antibiotic Resistance in. PLoS Pathog 7(6): e32767. doi:10.1371/journal.ppat.1002103
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002103
Souhrn
The wide utilization of biocides poses a concern on the impact of these compounds on natural bacterial populations. Furthermore, it has been demonstrated that biocides can select, at least in laboratory experiments, antibiotic resistant bacteria. This situation has raised concerns, not just on scientists and clinicians, but also on regulatory agencies, which are demanding studies on the impact that the utilization of biocides may have on the development on resistance and consequently on the treatment of infectious diseases and on human health. In the present article, we explored the possibility that the widely used biocide triclosan might induce antibiotic resistance using as a model the opportunistic pathogen Stenotrophomonas maltophilia. Biochemical, functional and structural studies were performed, focusing on SmeDEF, the most relevant antibiotic- and triclosan-removing multidrug efflux pump of S. maltophilia. Expression of smeDEF is regulated by the repressor SmeT. Triclosan released SmeT from its operator and induces the expression of smeDEF, thus reducing the susceptibility of S. maltophilia to antibiotics in the presence of the biocide. The structure of SmeT bound to triclosan is described. Two molecules of triclosan were found to bind to one subunit of the SmeT homodimer. The binding of the biocide stabilizes the N terminal domain of both subunits in a conformation unable to bind DNA. To our knowledge this is the first crystal structure obtained for a transcriptional regulator bound to triclosan. This work provides the molecular basis for understanding the mechanisms allowing the induction of phenotypic resistance to antibiotics by triclosan.
Zdroje
1. AielloAELarsonELLevySB 2007 Consumer antibacterial soaps: effective or just risky? Clin Infect Dis 45 Suppl 2 S137 147
2. De MuynckWDe BelieNVerstraeteW 2010 Antimicrobial mortar surfaces for the improvement of hygienic conditions. J Appl Microbiol 108 62 72
3. MoretroTSonerudTMangelrodELangsrudS 2006 Evaluation of the antibacterial effect of a triclosan-containing floor used in the food industry. J Food Prot 69 627 633
4. JonesRDJampaniHBNewmanJLLeeAS 2000 Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 28 184 196
5. SjoblomMAinamoAAinamoJ 1976 Antimicrobial effect of four different toothpastes. Scand J Dent Res 84 377 380
6. MeyerBCooksonB 2010 Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control? J Hosp Infect 76 200 205
7. AielloAELarsonE 2003 Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infect Dis 3 501 506
8. LevySB 2001 Antibacterial household products: cause for concern. Emerg Infect Dis 7 512 515
9. LevySB 2002 Active efflux, a common mechanism for biocide and antibiotic resistance. Symp Ser Soc Appl Microbiol 65S 71S
10. MasedaHHashidaYKonakaRShiraiAKouraiH 2009 Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens. Antimicrob Agents Chemother 53 5230 5235
11. SanchezPMorenoEMartinezJL 2005 The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother 49 781 782
12. YazdankhahSPScheieAAHoibyEALunestadBTHeirE 2006 Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist 12 83 90
13. BhargavaHNLeonardPA 1996 Triclosan: applications and safety. Am J Infect Control 24 209 218
14. ChuanchuenRBeinlichKHoangTTBecherAKarkhoff-SchweizerRR 2001 Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 45 428 432
15. McMurryLMOethingerMLevySB 1998 Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 166 305 309
16. AlonsoACampanarioEMartinezJL 1999 Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145 Pt 10 2857 2862
17. Join-LambertOFMichea-HamzehpourMKohlerTChauFFaurissonF 2001 Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Antimicrob Agents Chemother 45 571 576
18. KohlerTMichea-HamzehpourMPlesiatPKahrALPechereJC 1997 Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 41 2540 2543
19. GrkovicSBrownMHSkurrayRA 2002 Regulation of bacterial drug export systems. Microbiol Mol Biol Rev 66 671 701
20. MartinezJLSanchezMBMartinez-SolanoLHernandezAGarmendiaL 2009 Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 33 430 449
21. VilaJMartinezJL 2008 Clinical impact of the over-expression of efflux pump in nonfermentative gram-negative bacilli, development of efflux pump inhibitors. Curr Drug Targets 9 797 807
22. BrooksBEPiroKMBrennanRG 2007 Multidrug-binding transcription factor QacR binds the bivalent aromatic diamidines DB75 and DB359 in multiple positions. J Am Chem Soc 129 8389 8395
23. AlguelYMengCTeranWKrellTRamosJL 2007 Crystal structures of multidrug binding protein TtgR in complex with antibiotics and plant antimicrobials. J Mol Biol 369 829 840
24. TeranWFelipeASeguraARojasARamosJL 2003 Antibiotic-dependent induction of Pseudomonas putida DOT-T1E TtgABC efflux pump is mediated by the drug binding repressor TtgR. Antimicrob Agents Chemother 47 3067 3072
25. SchumacherMAMillerMCGrkovicSBrownMHSkurrayRA 2001 Structural mechanisms of QacR induction and multidrug recognition. Science 294 2158 2163
26. HeldweinEEBrennanRG 2001 Crystal structure of the transcription activator BmrR bound to DNA and a drug. Nature 409 378 382
27. WadeH 2010 MD recognition by MDR gene regulators. Curr Opin Struct Biol 20 489 496
28. BergGEberlLHartmannA 2005 The rhizosphere as a reservoir for opportunistic human pathogenic bacteria. Environ Microbiol 7 1673 1685
29. Ribbeck-BuschKRoderAHasseDde BoerWMartinezJL 2005 A molecular biological protocol to distinguish potentially human pathogenic Stenotrophomonas maltophilia from plant-associated Stenotrophomonas rhizophila. Environ Microbiol 7 1853 1858
30. SanchezMBHernandezAMartinezJL 2009 Stenotrophomonas maltophilia drug resistance. Future Microbiol 4 655 660
31. LooneyWJNaritaMMuhlemannK 2009 Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9 312 323
32. FalagasMEKastorisACVouloumanouEKRafailidisPIKapaskelisAM 2009 Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 4 1103 1109
33. WangWSLiuCPLeeCMHuangFY 2004 Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 37 359 365
34. CrumNFUtzGCWallaceMR 2002 Stenotrophomonas maltophilia endocarditis. Scand J Infect Dis 34 925 927
35. AisenbergGRolstonKVDickeyBFKontoyiannisDPRaadII 2007 Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004. Eur J Clin Microbiol Infect Dis 26 13 20
36. TurrientesMCBaqueroMRSanchezMBValdezateSEscuderoE 2010 Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl Environ Microbiol 76 1746 1758
37. ValdezateSVindelAMaizLBaqueroFEscobarH 2001 Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991–1998. Emerg Infect Dis 7 113 122
38. SpicuzzaLSciutoCVitalitiGDi DioGLeonardiS 2008 Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur J Clin Microbiol Infect Dis 28 191 195
39. RyanRPMonchySCardinaleMTaghaviSCrossmanL 2009 The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Micro 7 514 525
40. CrossmanLCGouldVCDowJMVernikosGSOkazakiA 2008 The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9 R74
41. AvisonMBHigginsCSFordPJvon HeldreichCJWalshTR 2002 Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia. J Antimicrob Chemother 49 387 389
42. OkazakiAAvisonMB 2007 Aph(3′)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 51 359 360
43. OkazakiAAvisonMB 2008 Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator. Antimicrob Agents Chemother 52 1525 1528
44. SanchezMBHernandezARodriguez-MartinezJMMartinez-MartinezLMartinezJL 2008 Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiology 8 148
45. SanchezMBMartinezJL 2010 SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 54 580 581
46. ShimizuKKikuchiKSasakiTTakahashiNOhtsukaM 2008 Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 52 3823 3825
47. ZhangLLiXZPooleK 2001 SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 45 3497 3503
48. AlonsoAMartinezJL 2001 Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 45 1879 1881
49. AlonsoAMartinezJL 2000 Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44 3079 3086
50. AlonsoAMartinezJL 1997 Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 41 1140 1142
51. SanchezPAlonsoAMartinezJL 2004 Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of the multidrug efflux pump SmeDEF. Antimicrob Agents Chemother 48 2274 2276
52. AlonsoAMoralesGEscalanteRCampanarioESastreL 2004 Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. Journal of Antimicrobial Chemotherapy 53 432 434
53. HernandezAMateMJSanchez-DiazPCRomeroARojoF 2009 Structural and Functional Analysis of SmeT, the Repressor of the Stenotrophomonas maltophilia Multidrug Efflux Pump SmeDEF. J Biol Chem 284 14428 14438
54. SanchezPAlonsoAMartinezJL 2002 Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob Agents Chemother 46 3386 3393
55. RamosJLMartinez-BuenoMMolina-HenaresAJTeranWWatanabeK 2005 The TetR family of transcriptional repressors. Microbiol Mol Biol Rev 69 326 356
56. NatsumeROhnishiYSendaTHorinouchiS 2004 Crystal structure of a gamma-butyrolactone autoregulator receptor protein in Streptomyces coelicolor A3(2). J Mol Biol 336 409 419
57. DoverLGCorsinoPEDanielsIRCocklinSLTatituriV 2004 Crystal structure of the TetR/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance. J Mol Biol 340 1095 1105
58. GuRSuCCShiFLiMMcDermottG 2007 Crystal structure of the transcriptional regulator CmeR from Campylobacter jejuni. J Mol Biol 372 583 593
59. LiMGuRSuCCRouthMDHarrisKC 2007 Crystal structure of the transcriptional regulator AcrR from Escherichia coli. J Mol Biol 374 591 603
60. WillemsARTahlanKTaguchiTZhangKLeeZZ 2008 Crystal structures of the Streptomyces coelicolor TetR-like protein ActR alone and in complex with actinorhodin or the actinorhodin biosynthetic precursor (S)-DNPA. J Mol Biol 376 1377 1387
61. JengWYKoTPLiuCIGuoRTLiuCL 2008 Crystal structure of IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis. Nucleic Acids Res 36 1567 1577
62. KrellTTeranWMayorgaOLRivasGJimenezM 2007 Optimization of the palindromic order of the TtgR operator enhances binding cooperativity. J Mol Biol 369 1188 1199
63. KapoorMReddyCCKrishnasastryMVSuroliaNSuroliaA 2004 Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. Biochem J 381 719 724
64. SchumacherMAMillerMCGrkovicSBrownMHSkurrayRA 2002 Structural basis for cooperative DNA binding by two dimers of the multidrug-binding protein QacR. EMBO J 21 1210 1218
65. LiXZZhangLPooleK 2002 SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 46 333 343
66. ChangLLChenHFChangCYLeeTMWuWJ 2004 Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 53 518 521
67. PumbweLChangASmithRLWexlerHM 2006 Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates. J Antimicrob Chemother 58 543 548
68. CottellADenyerSPHanlonGWOchsDMaillardJY 2009 Triclosan-tolerant bacteria: changes in susceptibility to antibiotics. J Hosp Infect 72 71 76
69. BaileyAMConstantinidouCIvensAGarveyMIWebberMA 2009 Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J Antimicrob Chemother 64 973 985
70. CalabreseEJ 2005 Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ Pollut 138 379 411
71. LeslieAG 2006 The integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr 62 48 57
72. CCP4 1994 The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50 760 763
73. VaginATeplyakovA 1997 MOLREP: an Automated Program for Molecular Replacement. J Appl Cryst 30 1022 1025
74. PainterJMerrittEA 2006 TLSMD web server for the generation of multi-group TLS models. J Appl Cryst 39 109 111
75. EmsleyPLohkampBScottWGCowtanK 2010 Features and Development of Coot. Acta Crystallographica Section D - Biological Crystallography 66 22 25
76. MurshudovGNVaginAADodsonEJ 1997 Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53 240 255
77. ChenVBArendallWB3rdHeaddJJKeedyDAImmorminoRM 2010 MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66 12 21
78. MerrittEA 1999 Expanding the Model: Anisotropic Displacement Parameters in Protein Structure Refinement. Acta Crystallographica D 55 1109 1117
79. KrissinelEHenrickK 2007 Inference of macromolecular assemblies from crystalline state. J Mol Biol 372 774 797
80. DundasJOuyangZTsengJBinkowskiATurpazY 2006 CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34 W116 118
81. DeLanoWL 2002 The PyMOL Molecular Graphics System. DeLano Scientifics, Palo Alto, CA, USA
82. MoralesGUgidosARojoF 2006 Inactivation of the Pseudomonas putida cytochrome o ubiquinol oxidase leads to a significant change in the transcriptome and to increased expression of the CIO and cbb3-1 terminal oxidases. Environ Microbiol 8 1764 1774
83. GouldVCAvisonMB 2006 SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J Antimicrob Chemother 57 1070 1076
84. LivakKJSchmittgenTD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402 408
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 6
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- High Affinity Nanobodies against the VSG Are Potent Trypanolytic Agents that Block Endocytosis
- Structural and Mechanistic Studies of Measles Virus Illuminate Paramyxovirus Entry
- Sporangiospore Size Dimorphism Is Linked to Virulence of
- Uses Host Triacylglycerol to Accumulate Lipid Droplets and Acquires a Dormancy-Like Phenotype in Lipid-Loaded Macrophages